Systemic melanoma therapy at the end of life: A single institutional retrospective study in Japan

JAAD Int. 2022 Nov 11:10:51-52. doi: 10.1016/j.jdin.2022.11.001. eCollection 2023 Mar.

Ayumi Yoto^{1

2}, Kanade Shimada^{1

3}, Sumiko Takatsuka¹, Tatsuya Takenouchi¹

¹ Division of Dermatology, Niigata Cancer Center Hospital, Niigata, Japan.
² Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan.
³ Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

No abstract available

Keywords: BRAF/MEK inhibitors; drug treatment; end of life; immune checkpoint inhibitors; melanoma; terminal stage.